Haixia Guan

7.3k total citations · 1 hit paper
150 papers, 4.3k citations indexed

About

Haixia Guan is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Haixia Guan has authored 150 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Endocrinology, Diabetes and Metabolism, 41 papers in Molecular Biology and 24 papers in Oncology. Recurrent topics in Haixia Guan's work include Thyroid Disorders and Treatments (52 papers), Thyroid Cancer Diagnosis and Treatment (47 papers) and Cancer-related Molecular Pathways (10 papers). Haixia Guan is often cited by papers focused on Thyroid Disorders and Treatments (52 papers), Thyroid Cancer Diagnosis and Treatment (47 papers) and Cancer-related Molecular Pathways (10 papers). Haixia Guan collaborates with scholars based in China, United States and Italy. Haixia Guan's co-authors include Weiping Teng, Zhongyan Shan, Meiju Ji, Peng Hou, Mingzhao Xing, Di Wu, Cheng Han, Jianqiu Gu, Xinghai Xia and Rui Liu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Haixia Guan

146 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis

2015 465 citations Haixia Guan, Zhongyan Shan et al. BioMed Research International profile →

Peers

Haixia Guan

EDM

ONCOL

PFM

SURGE

Yangang Wang China

Bernhard Paulweber Austria

Keizo Kanasaki Japan

Peter Alexandersen Denmark

Chuan‐Ming Hao China

Atsushi Fukatsu Japan

Naoki Kashihara Japan

Riccardo Candido Italy

Jean‐Luc Wautier France

Yiming Mu China

Yangang Wang China

Haixia Guan

1.2k ×0.5

EDM

1.1k ×0.7

414 ×0.6

ONCOL

316 ×0.5

PFM

711 ×1.3

SURGE

Citations per year, relative to Haixia Guan Haixia Guan (= 1×) peers Yangang Wang

Countries citing papers authored by Haixia Guan

Since Specialization

Citations

This map shows the geographic impact of Haixia Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haixia Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haixia Guan more than expected).

Fields of papers citing papers by Haixia Guan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haixia Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haixia Guan. The network helps show where Haixia Guan may publish in the future.

Co-authorship network of co-authors of Haixia Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Haixia Guan. A scholar is included among the top collaborators of Haixia Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haixia Guan. Haixia Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yu, Haixia Guan, Xinliang Feng, et al.. (2025). Emerging strategies in colorectal cancer immunotherapy: enhancing efficacy and survival. Frontiers in Immunology. 16. 1616414–1616414. 1 indexed citations

Guan, Haixia, et al.. (2025). Long‐term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post‐hoc analysis of SURPASS ‐4. Diabetes Obesity and Metabolism. 27(11). 6480–6490.

Yang, Shuai, Yong Zhang, Yanan Li, et al.. (2025). Association of Maternal Thyroglobulin Antibody With Preterm Birth in Euthyroid Women. The Journal of Clinical Endocrinology & Metabolism. 110(11). e3841–e3849. 1 indexed citations

Yan, Kai, Qingzhi Liu, Rongrong Huang, et al.. (2024). Spatial transcriptomics reveals prognosis‐associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment. Clinical and Translational Medicine. 14(3). e1594–e1594. 13 indexed citations

Zhu, Tianyi, et al.. (2024). Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED. The Journal of Clinical Endocrinology & Metabolism. 110(6). 1537–1549. 2 indexed citations

Ma, Chi, Nasha Zhang, Teng Wang, et al.. (2023). Inflammatory cytokine-regulated LNCPTCTS suppresses thyroid cancer progression via enhancing Snail nuclear export. Cancer Letters. 575. 216402–216402. 12 indexed citations

Fu, Jinrong, Zihao Fan, Liang He, et al.. (2023). Circadian clock disruption in autoimmune thyroiditis. European Thyroid Journal. 12(5). 8 indexed citations

Chen, Zhijiang, Shuiqing Lai, Peiqing Wang, et al.. (2022). The utility of serum anti-thyroglobulin antibody and thyroglobulin in the preoperative differential diagnosis of thyroid follicular neoplasms. Endocrine. 76(2). 369–376. 10 indexed citations

Su, Xi, Dong Chen, Jia Hao, et al.. (2022). SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition. Cell Death and Disease. 13(3). 218–218. 12 indexed citations

10.

Lu, Ke, Long Wang, Shuiqing Lai, et al.. (2022). A new discriminant strategy combined with four TIRADS screening procedures increases ultrasound diagnostic accuracy—focusing on “wrong diagnostic” thyroid nodules. European Radiology. 33(2). 784–796. 4 indexed citations

11.

Hou, Xin, Haixia Guan, Shuang Sun, et al.. (2022). Outcomes of Early-Pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-Up Study. Thyroid. 32(8). 983–989. 5 indexed citations

12.

Guan, Haixia & Connie M. Rhee. (2020). Directionality of Effects from Thyroid to Kidney Function Is Supported by a Mendelian Randomization Study. Clinical Thyroidology. 32(3). 106–109. 1 indexed citations

13.

Qu, Ning, Xiao Shi, Jingjing Zhao, et al.. (2020). Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma. Thyroid. 30(7). 1025–1036. 14 indexed citations

14.

Amraei, Razie, Gianluca Toraldo, Haixia Guan, et al.. (2020). ThyroSeq v2 Testing: Impact on Cytologic Diagnosis, Management, and Cost of Care in Patients with Thyroid Nodule. Thyroid. 30(10). 1528–1534. 20 indexed citations

15.

Jia, Mengwei, Xiaoguang Shi, Xiaolan Gu, et al.. (2018). Smoking Is Positively Associated with Antithyroperoxidase Antibodies and Antithyroglobulin Antibodies in Populations with Mildly Deficient Iodine Intake. Biological Trace Element Research. 187(2). 383–391. 5 indexed citations

16.

Liu, Yongping, Shanshan Liu, Jinyuan Mao, et al.. (2018). Serum Trace Elements Profile in Graves’ Disease Patients with or without Orbitopathy in Northeast China. BioMed Research International. 2018. 1–8. 28 indexed citations

17.

Wang, Na, Wei Jing, Jun Pu, et al.. (2018). TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways. Thyroid. 29(3). 378–394. 40 indexed citations

18.

Qin, Jing, Jin Zhou, Chenling Fan, et al.. (2017). Increased Circulating Th17 but Decreased CD4⁺Foxp3⁺ Treg and CD19⁺CD1d^hiCD5⁺ Breg Subsets in New-Onset Graves’ Disease. BioMed Research International. 2017. 1–8. 45 indexed citations

19.

Zhao, Yuhang, Wei Miao, Chenyang Li, et al.. (2014). Dynamic Changes in Serum 25-Hydroxyvitamin D during Pregnancy and Lack of Effect on Thyroid Parameters. PLoS ONE. 9(3). e90161–e90161. 14 indexed citations

20.

Guan, Haixia, Meiju Ji, Peng Hou, et al.. (2008). Hypermethylation of the DNA mismatch repair gene hMLH1 and Its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer. Cancer. 113(2). 247–255. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact